Presenting characteristics and clinical outcomes of idiopathic versus neurofibromatosis type 2-associated spinal meningiomas: a retrospective institutional experience. [PDF]
Nawabi NLA +8 more
europepmc +1 more source
Retinal Ischemia as a Presenting Ocular Sign of Neurofibromatosis Type 2. [PDF]
Zhao B, Yan Y.
europepmc +1 more source
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions. [PDF]
Yuan R, Wang B, Wang Y, Liu P.
europepmc +1 more source
Longitudinal Performance of Cochlear Implants in Neurofibromatosis Type 2. [PDF]
Seo S, Shen S, Ding AS, Creighton FX.
europepmc +1 more source
Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials. [PDF]
Thompson HL +4 more
europepmc +1 more source
Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis. [PDF]
Nagel A +6 more
europepmc +1 more source
Case Report: Contralateral Progression of a Vestibular Schwannoma After Resection in a Patient with Neurofibromatosis Type 2. [PDF]
Rampalli I +10 more
europepmc +1 more source

